Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- Check6 days agoChange DetectedFooter revision label updated from v3.6.5 to v3.6.6, indicating a maintenance update to the ClinicalTrials.gov page. The change does not modify the study details or embedded content.SummaryDifference0.0%

- Check13 days agoChange DetectedThe study record’s update history received new entries for 2026-08-21 and 2026-08-25, while older entries for 2026-07-15 and 2026-07-16 were removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe revision tag on the page was updated to v3.6.5, replacing the previous v3.6.4, indicating a small page version update.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version for internal tracking.SummaryDifference0.0%

- Check48 days agoChange DetectedUT MD Anderson Cancer Center was added as a participating site in the study record (dated 2026-07-15/16). The prior entry for MD Anderson Cancer Center, listed as 'M D Anderson Cancer Center', was removed (dated 2026-04-16/21).SummaryDifference0.1%

- Check63 days agoChange Detected- The page revision was updated from v3.6.2 to v3.6.3. This update reflects a version change and does not modify the study content or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.